CELYAD SA

Codice
cyad
Risorse esterne
Opinione della community
Prezzo Variazione Volume
60.11 -0.32 €
(-0.53%)
18953
P/E Obiettivo ad 1anno
0 68 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 18
Sell : 8

Marco Di Folco LucaMazzu91

Commenti


Notizie

Is Celyad Sa Ads (CYAD) Headed For a Near-Term Reversal? - Stock Talker

Celyad Sa Ads (CYAD) shares have seen the Money Flow Indicator climb above 60, potentially spelling a near-term reversal if it crosses above the 70 line. ... Many investors will use the CCI in conjunction with other indicators when evaluating a trade ...altro » Leggi

Celyad SA (NASDAQ:CYAD) Earns Media Impact Score of 0.19 - The Ledger Gazette

Shares of Celyad SA (CYAD) traded down 0.32% during trading on Friday, hitting $60.11. The stock had a trading volume of 18,953 shares. The company's market capitalization is $572.31 million. Celyad SA has a 1-year low of $16.31 and a 1-year high of ... Leggi

Celyad SA – American Depositary (NASDAQ:CYAD) Trading ... - First News 24

Trading volume for Celyad SA – American Depositary was 12K on Friday. Shares saw a steep increase in trading volume of 332.66% over the normal average daily volume. Traders are feeling more bullish on shares of the company recently at least if you ... Leggi

Celyad Sa Ads (CYAD) Shares Trickle Lower For the Week - Trion Journal (blog)

Traders are keeping a keen eye on shares of Celyad Sa Ads (CYAD). The Average Directional Index or ADX may prove to be an important tool for trading and investing. The ADX is a technical indicator developed by J. Welles Wilder used to determine the ...altro » Leggi

25 Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Celyad SA (ADR) (NASDAQ: CYAD) shares fell 4.9 percent to $58.90 in pre-market trading after gaining 5.32 percent on Tuesday. NewLink Genetics Corp (NASDAQ: NLNK) fell 4.8 percent to $10.40. NewLink Genetics priced 5 million share common stock ... Leggi

Celyad : Des premiers résultats prometteurs pour THINK - TradingSat

(CercleFinance.com) - Le titre Celyad a le vent en poupe ce mardi, engrangeant près de 5% consécutivement à l'annonce de premiers résultats cliniques prometteurs du premier niveau de dose dans le groupe des tumeurs hématologiques de son étude ...altro » Leggi

Celyad SA – American Depositary (NASDAQ:CYAD) Experiences ... - Modern Readers

(NASDAQ:CYAD) shares saw light trading volume with 200 shares changing hands in the last trading session. Volume was down 92.89% under the stocks average daily volume. Traders are feeling more bullish lately if you look at the change in short interest.altro » Leggi

Earnings Yield and Valuation Review For Celyad SA (ENXTBR:CYAD) - DARC News

The ERP5 of Celyad SA (ENXTBR:CYAD) is 15199. The lower the ERP5 rank, the more undervalued a company is thought to be. Looking further, the MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.altro » Leggi

Celyad SA (ADR) (CYAD) on Focus After Trading At 52-Week Highs - Weekly Register

The stock of Celyad SA (ADR) (NASDAQ:CYAD) hit a new 52-week high and has $61.39 target or 8.00 % above today's $56.84 share price. The 7 months bullish chart indicates low risk for the $515.33M company. The 1-year high was reported on Sep, 22 by ... Leggi

Celyad: First “Clinical Validity” For NKR CAR T-Cells - Investing.com

Celyad SA (NASDAQ:CYAD) has reported a complete morphological leukaemia-free status (MFLS) response in acute myeloid leukaemia (AML) in the NKR CAR T-cell THINK study. Given that spontaneous remission in refractory/relapsed AML is extremely ...altro » Leggi